Cradle

Cradle is the Molecular Engineering Platform built for the full design-to-candidate lifecycle. The company's enterprise AI software enables scientists to design, engineer, optimize, and advance proteins and peptides from hit generation through preclinical candidate selection within a single, continuously learning workflow. By combining protein language models, experimental data, and scientific expertise, Cradle helps organizations engineer molecules that satisfy the many properties required for downstream success, accelerating biological innovation while increasing the probability of success.

 

Cradle is trusted by many of the world's top 25 pharmaceutical companies and is used across dozens of research and development programs spanning therapeutics, industrial biotechnology, food, agriculture, and other biological products. The platform enables scientists to move from target to candidate faster while continuously learning from every experiment to improve future decisions.

Founded in 2021, Cradle is headquartered in Amsterdam, the Netherlands, with offices in Zurich, Switzerland, and the United States. Its multidisciplinary team brings together experts in machine learning, software engineering, and biotechnology from organizations including Google DeepMind, Google, Meta, Novartis, Uber, Zymergen, and Generate Biomedicines. Cradle is backed by IVP, Index Ventures, and Kindred Capital. For more information, visit cradle.bio.

Visit website (opens in a new tab)
Loading
View All (opens in a new tab)

Contact Exhibitor